July 1, 2022
Teva Announces Appointment of New Global R&D and Chief Medical Officer
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eric A. Hughes, MD,…
Pharmaceuticals, Biotechnology and Life Sciences
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eric A. Hughes, MD,…
SUWON, South Korea–(BUSINESS WIRE)–#AMD—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced the submission of an…
ST. HELIER, Jersey–(BUSINESS WIRE)–$NVCR–Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2022 on…
Ameet Mallik, Chief Executive Officer of ADC Therapeutics, also joins the Board LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT) today…
DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Non-Hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027” report has…
Australian approval follows recent trial approval by regulatory authorities in France MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN), a…
SHANGHAI, China, July 01, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing…
BOSTON, June 30, 2022 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of…
-Rapid, profound and durable responses across multiple dosing groups with favorable safety profile–Mean reduction from baseline in urticaria activity (UAS7)…
NEW YORK, June 30, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery…